Feature Channels: Vaccines

• share
• favorite_border

The 2022 "Highly Cited Researchers" list from Clarivate includes several La Jolla Institute for Immunology (LJI) scientists well versed in lay friendly communication. These experts are ready to share exciting new research with media and podcast outlets. Contact [email protected] to set up an interview and make arrangements for high quality audio capture.

• share
• favorite_border

An international study led by McMaster University researchers and published in The Lancet Global Health has found that influenza vaccines greatly reduce both pneumonia and cardiovascular complications in people with heart failure. An international study led by McMaster University researchers and published in The Lancet Global Health has found that influenza vaccines greatly reduce both pneumonia and cardiovascular complications in people with heart failure. Data gathered during flu season also showed the vaccine helped protect against cardiovascular complications, such as heart attacks and strokes.

• share
• favorite_border

A research team led by the University of Houston has developed a vaccine targeting the dangerous synthetic opioid fentanyl that could block its ability to enter the brain, thus eliminating the drug’s “high.”

• share
• favorite_border

mRNA vaccines for COVID-19 generate adverse reactions such as fever and fatigue which are considered normal and are transient in nature.

• share
• favorite_border

This World Pneumonia Day, Nov. 12, 2022, the Forum of International Respiratory Societies (FIRS), of which the American Thoracic Society is a founding member, is calling on governments and other stakeholders to take urgent action to tackle pneumonia - focusing on those who are at greatest risk of severe illness.

• share
• favorite_border

A new study from Washington University School of Medicine in St. Louis and the Veterans Affairs St. Louis Health Care system shows the health consequences of COVID-19 reinfection. The researchers found that repeat SARS-CoV-2 infections contribute significant additional risk of adverse health conditions in multiple organ systems. Such outcomes include hospitalization; disorders affecting the lungs, heart, brain, and the body’s blood, musculoskeletal and gastrointestinal systems; and even death. Reinfection also contributes to diabetes, kidney disease and mental health issues.

• share
• favorite_border

Here are some of the latest articles that have been added to the Arthritis channel on Newswise.

• share
• favorite_border

Cases of respiratory illnesses – particularly RSV – are on the rise. A Penn State Health Children’s Hospital infectious disease physician explains why, and what you can do.

• share
• favorite_border

Pregnant people who received one of the mRNA COVID-19 vaccines had 10-fold higher antibody concentrations than those who were naturally infected with SARS-CoV-2, a finding that was also observed in their babies, according to a new study by researchers at Children’s Hospital of Philadelphia (CHOP) and the University of Pennsylvania. The study, published today in JAMA Network Open, also found that vaccine timing played an important role in maximizing the transfer of antibodies, with antibodies detected as early as 15 days after the first vaccine dose and increasing for several weeks after.

• share
• favorite_border

Despite centuries of research, treating and curing cancer remains an urgent health research priority. With generous support from anonymous donors, the GastroIntestinal Research Foundation (GIRF) has launched a bold initiative, CA CURE, to identify and fund research to improve diagnostics and develop therapeutics focused on immunotherapies and personalized vaccines.

• share
• favorite_border

An early pandemic survey found that respondents’ intentions to receive COVID-19 vaccines were linked more to their media literacy and opinion of health experts than knowledge of the virus or previous vaccination behavior.

• share
• favorite_border

A new study conducted in England shows that the risk of death due to COVID-19 remains very low for children and young people, and most deaths occur in those with underlying health conditions. Marta Bertran of the UK Health Security Agency, London, and colleagues present these findings on November 8th in the open access journal PLOS Medicine.

• share
• favorite_border

New research presented this week at ACR Convergence 2022, the American College of Rheumatology’s annual meeting, showed that a higher dose of pneumococcal vaccine safely and effectively improved antibody response in patients receiving rituximab for ANCA-associated vasculitis.

• share
• favorite_border

New research presented this week at ACR Convergence, the American College of Rheumatology’s annual meeting, showed that discontinuing methotrexate for 1 week after seasonal influenza vaccination provided the same seroprotection as a 2 week discontinuation period in patients with RA.

• share
• favorite_border

New research presented this week at ACR Convergence 2022, the American College of Rheumatology’s annual meeting, demonstrated that withholding mycophenolate mofetil for 10 days significantly increased antibody response after 2 doses of COVID-19 vaccine, without a significant increase in flares.

• share
• favorite_border

New research presented this week at ACR Convergence 2022, the American College of Rheumatology’s annual meeting, found a greater number of preterm births in unvaccinated versus fully vaccinated pregnant patients with rheumatic disease and COVID-19.

• share
• favorite_border

Researchers comparing pre and post-pandemic surveys have found confidence in vaccinations is considerably lower post pandemic amongst all demographic groups.

• share
• favorite_border

Many more Utah teens are getting vaccinated for HPV, protecting them against six types of cancer. The state saw a significant increase in HPV vaccinations after a long history of mixed messages and misunderstandings about the vaccine. Huntsman Cancer Institute experts explain what’s working, and one woman tells about her harrowing cancer journey.

• share
• favorite_border

• In a population-level study of 1,105 adults with stable glomerular disease (a type of autoimmune kidney disease), a first dose of a COVID-19 vaccine was not associated with relapse risk; however, receiving a subsequent vaccine dose was associated with a 2-fold higher relative risk of relapse. • Importantly, the increase in absolute risk associated with vaccination was low (1–5% depending on type of glomerular disease), and most vaccine-associated disease flares were mild.

• share
• favorite_border

• share
• favorite_border

Respiratory illnesses are affected the United States as winter approaches, and a "tridemic" is possible with the flu, COVID-19 and RSV.

• share
• favorite_border

Free flu clinic. No registration needed.

• share
• favorite_border

COVID-19 vaccinations effectively reduce severe symptoms, hospitalizations, and death, which is why the Centers of Disease Control’s Advisory Committee on Immunization Practices will vote to add the COVID-19 vaccine to the recommended vaccine schedule for children.

• share
• favorite_border

Cancer immunotherapies, such as immune checkpoint inhibition therapy, have been attracting attention in recent years as new methods for treating cancer.

• share
• favorite_border

A Roundup of the Latest Medical Discoveries and Faculty News at Cedars-Sinai

• share
• favorite_border

Children aged 8 years or younger should be considered a group at high risk for more severe monkeypox disease, reports The Pediatric Infectious Disease Journal, the official journal of The European Society for Pediatric Infectious Diseases. The journal is published in the Lippincott portfolio by Wolters Kluwer.

• share
• favorite_border

Keeping your child safe and healthy is a multifaceted priority for families, starting with the ride home from the hospital in a properly installed car seat.

• share
• favorite_border

UC San Diego will be one of multiple sites assessing the safety and efficacy of tecovirimat as a potential treatment for human monkeypox. Marketed as TPOXX, tecovirimat is an antiviral currently approved for treatment of human smallpox in adults and children caused by the variola virus.

• share
• favorite_border

New research led by researchers at the University of Miami Miller School of Medicine and published in the Journal of Hepatology, suggests that getting a third dose of the COVID-19 mRNA vaccine could overcome the decreased vaccine respons in cirrhosis patients and offer strong protection against the virus, severe illness, and death from COVID-19.

• share
• favorite_border

The LJI team plans to use their new map of the Lassa virus surface glycoprotein to design a much-needed vaccine.

• share
• favorite_border

The Global Virus Network (GVN), representing 68 Centers of Excellence and 11 Affiliates in 39 countries comprising foremost experts in every class of virus causing disease in humans, and the Mahidol University in Thailand announced the addition of the Mahidol Virus Network as GVN’s newest Center of Excellence.

• share
• favorite_border

A subset of healthcare workers vaccinated against COVID-19 had unexpectedly low responses to the immunizations, according to Cedars-Sinai investigators. The findings of the new study are published in iScience, a Cell Press journal.